Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
B
Details...
Enter Symbol
OPEXA THERAPEUTICS (NASDAQ: OPXA)
Sector: Medical
Current Price :
$1.69
52 Week Low
$1.12
52 Week High
$3.28
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
7M
Market Cap:
$0.01B
Avg Volume:
568267
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 12/17/2012 opxa split by factor of 0.250
Opinion and Analysis
Life Technologies (LIFE) Product For Culturing T-Cell Gets FDA 510(K) Approval
Sep 27, 2012 09:36 AM |
OPXA
Late Snapback Pares Losses In Down Session
Jan 19, 2011 10:24 PM |
AAPL
,
ADTN
,
AIG
,
AMZN
,
APKT
,
ASYS
Market Traded In Red As Banks Disappoints, Financial Sector Lost Ground
Jan 19, 2011 06:37 PM |
AMR
,
AXP
,
BAC
,
C
,
GS
,
IBCP
More Articles on OPXA..
Press Releases
Opexa Therapeutics, Inc. [OPXA] to Ring The NASDAQ Stock Market Closing Bell
May 24, 2013 10:00 AM |
NDAQ
,
OPXA
Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update
May 14, 2013 06:00 AM |
OPXA
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results
May 10, 2013 09:00 AM |
OPXA
More Press Releases on OPXA..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
OPXA
Compare to S&P
YTD
48.56 %
36.23 %
4 Weeks
-17.16 %
-17.07 %
12 Weeks
33.07 %
28.60 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
0.00 %
EPS Growth in Last Year:
-50.00 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##